Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Alings, M A"'
Publikováno v:
Patient Related Outcome Measures, Vol Volume 13, Pp 145-155 (2022)
Eva Zwaan,1,* Elena Cheung,1,2,* Alexander IJsselmuiden,2 Carlo Holtzer,3 Ton Schreuders,4 Marcel Kofflard,5 Marco Alings,2 J Henk Coert1 1Department of Plastic and Reconstructive Surgery, University Medical Center Utrecht, Utrecht, the Nethe
Externí odkaz:
https://doaj.org/article/6220a03855fc48b6924a71f42931b53c
Autor:
Verheul, L M, Guglielmo, M, Groeneveld, S A, Kirkels, F P, Scrocco, C, Cramer, M J, Bootsma, M, Kapel, G F L, Alings, M, Evertz, R, Mulder, B A, Prakken, N H J, Balt, J C, Volders, P G A, Hirsch, A, Yap, S C, Postema, P G, Nijveldt, R, Velthuis, B K, Behr, E R
Publikováno v:
European Heart Journal - Cardiovascular Imaging; Jun2024, Vol. 25 Issue 6, p764-770, 7p
Publikováno v:
Vascular Health and Risk Management, Vol Volume 15, Pp 399-408 (2019)
Jaap Seelig,1 Ron Pisters,1 Martin E Hemels,1,2 Menno V Huisman,3 Hugo ten Cate,4,5 Marco Alings6 1Department of Cardiology, Rijnstate Hospital, Arnhem, The Netherlands; 2Department of Cardiology, Radboud University Medical Center, Nijmegen, The Neth
Externí odkaz:
https://doaj.org/article/bc4a1daf82b84d9aab1271538d8a0b04
Autor:
Groeneveld, S.A., Verheul, L.M., Ree, M.H. van der, Mulder, Barbara J.M., Scholten, M.F., Alings, M., Voort, P. van der, Bootsma, M., Evertz, R., Balt, J.C., Yap, S.C., Doevendans, P.A., Postema, P.G., Wilde, A.A., Volders, P.G., Hassink, R.J.
Publikováno v:
JACC. Clinical Electrophysiology, 9, 3, pp. 345-355
JACC. Clinical Electrophysiology, 9, 345-355
JACC. Clinical Electrophysiology, 9, 345-355
Contains fulltext : 291532.pdf (Publisher’s version ) (Closed access) BACKGROUND: Idiopathic ventricular fibrillation (iVF) is a diagnosis of exclusion. Systematic diagnostic testing is important to exclude alternative causes for VF. The early use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4a4806d28c0ea2899744a9120f1057df
https://hdl.handle.net/2066/291532
https://hdl.handle.net/2066/291532
Autor:
Westenbrink, B.D. *, Alings, M., Connolly, S.J., Eikelboom, J., Ezekowitz, M.D., Oldgren, J., Yang, S., Pongue, J., Yusuf, S., Wallentin, L., van Gilst, W.H.
Publikováno v:
In Journal of Thrombosis and Haemostasis May 2015 13(5):699-707
Autor:
Knops, RE, Pepplinkhuizen, S, Delnoy, PPHM, Boersma, LVA, Kuschyk, J, El-Chami, MF, Bonnemeier, H, Behr, ER, Brouwer, TF, Kaab, S, Mittal, S, Quast, AFBE, van der Stuijt, W, Smeding, L, de Veld, JA, Tijssen, JGP, Bijsterveld, NR, Richter, S, Brouwer, MA, de Groot, JR, Kooiman, KM, Lambiase, PD, Neuzil, P, Vernooy, K, Alings, M, Betts, TR, Bracke, FALE, Burke, MC, de Jong, JSSG, Wright, DJ, Jansen, WPJ, Whinnett, ZI, Nordbeck, P, Knaut, M, Philbert, BT, van Opstal, JM, Chicos, AB, Allaart, CP, Borger van der Burg, AE, Dizon, JM, Miller, MA, Nemirovsky, D, Surber, R, Upadhyay, GA, Weiss, R, de Weger, A, Wilde, AAM, Olde Nordkamp, LRA
BACKGROUND: The subcutaneous ICD (S-ICD) is developed to overcome lead-related complications and systemic infections, inherent to transvenous ICD (TV-ICD) therapy. The PRAETORIAN trial demonstrated that the S-ICD is non-inferior to the TV-ICD with re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::cd249f588e408499c40702bf29fd2fb8
https://openaccess.sgul.ac.uk/id/eprint/114849/1/ehac496.pdf
https://openaccess.sgul.ac.uk/id/eprint/114849/1/ehac496.pdf
Autor:
Nguyen, Bao Oanh, Crijns, Harry J. G. M., Tijssen, Jan G. P., Geelhoed, Bastiaan, Hobbelt, Anne H., Hemels, Martin E. W., Mol, W. J. Myke, Weijs, Bob, Alings, Marco, Smit, Marcelle D., Tieleman, Robert G., Tukkie, Raymond, van Veldhuisen, Dirk J., van Gelder, Isabelle C., Rienstra, Michiel, van Gelder, I. C., Alings, M., Tieleman, R. G., Aksoy, I., Linssen, G. C. M., Bosker, H. A., Verdel, G. J. E., Cramer, E., Crijns, H. J. G. M., Tuininga, Y. S., van der Galiën, A., Hagens, V., de Ruiter, G. S.
Publikováno v:
Europace, 24(6), 910-920. Oxford University Press
Europace, 24, 6, pp. 910-920
Europace, 24(6). Oxford University Press
EP Europace, 24(6), 910-920. Oxford University Press
Europace, 24, 910-920
Europace, 24, 6, pp. 910-920
Europace, 24(6). Oxford University Press
EP Europace, 24(6), 910-920. Oxford University Press
Europace, 24, 910-920
Aims The Routine vs. Aggressive risk factor driven upstream rhythm Control for prevention of Early persistent atrial fibrillation (AF) in heart failure (HF) (RACE 3) trial demonstrated that targeted therapy of underlying conditions improved sinus rhy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c8e4bfb2a8c01292518bd6f3eed3579
https://doi.org/10.1093/europace/euab270
https://doi.org/10.1093/europace/euab270
Autor:
Han, H.C., Wang, J., Birnie, D.H., Alings, M., Philippon, F., Parkash, R., Manlucu, J., Angaran, P., Rinne, C., Coutu, B., Low, R.A., Essebag, V., Morillo, C., Healey, J.S., Redfearn, D., Toal, S., Becker, G., Degrâce, M., Thibault, B., Crystal, E., Tung, S., LeMaitre, J., Sultan, O., Bennett, M., Bashir, J., Ayala-Paredes, F., Gervais, P., Rioux, L., Hemels, M.E.W., Bouwels, L.H., Exner, D.V., Dorian, P., Connolly, S.J., Longtin, Y., Krahn, A.D.
Publikováno v:
JAMA Cardiology, 8, 5, pp. 484-491
JAMA Cardiology, 8, 484-491
JAMA Cardiology, 8, 484-491
ImportanceCardiac implantable electronic device (CIED) infection is a potentially devastating complication with an estimated 12-month mortality of 15% to 30%. The association of the extent (localized or systemic) and timing of infection with all-caus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47231aae1902f93b90e45e099ebfb0d6
https://doi.org/10.1001/jamacardio.2023.0467
https://doi.org/10.1001/jamacardio.2023.0467
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.